Elfabrio Prices, Coupons, Copay Cards & Patient Assistance
Elfabrio (pegunigalsidase alfa) is a member of the lysosomal enzymes drug class and is commonly used for Fabry Disease.
Elfabrio prices
Intravenous Solution
iwxj 2 mg/mL Elfabrio intravenous solution from $1,191.94 for 2.5 milliliters
| Quantity | Per unit | Price |
|---|---|---|
| 2.5 milliliters | $476.78 | $1,191.94 |
| 10 milliliters | $473.77 | $4,737.73 |
| 50 (5 x 10 milliliters) | $472.97 | $23,648.65 |
| 100 (10 x 10 milliliters) | $472.87 | $47,287.29 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Get your FREE Drugs.com Discount Card
Save up to 80% off the cost of prescription drugs and OTC medicines valid at over 65,000 pharmacies.
This is a drug discount program, not an insurance plan.
Elfabrio Coupons, Copay Cards and Rebates
Elfabrio offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Elfabrio Prescription Copay Program
Eligible commercially insured patients pay as little as $0 per prescription; patient must renew their eligibility in the program each calendar year.
- Applies to:
- Elfabrio
- Number of uses:
- Per prescription per calendar year
Form more information phone: 833-656-1056 or Visit website
Elfabrio Infusion Services Copay Program
Eligible commercially insured patients pay as little as $0 for infusion supplies and administration.
- Applies to:
- Elfabrio
- Number of uses:
- Per prescription per calendar year
Form more information phone: 833-656-1056 or Visit website
Patient Assistance & Copay Programs for Elfabrio
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Elfabrio (pegunigalsidase alfa-iwxj) Injection for Intravenous use
More information please phone: 866-316-7263 Visit website
Provider: Chiesi Total Care Program: Elfabrio
Eligibility requirements:- Contact program for details.
- Not disclosed
- FDA-approved diagnosis
- Must be residing in the US or a US territory, and under the care of a US physician
- Eligibility determined on a case-by-case basis. Please visit www.ChiesiTotalCare.com or call (833) 656-1056 for more information.
- Elfabrio (pegunigalsidase alfa-iwxj) Injection for Intravenous use
More information please phone: 833-656-1056 or 866-758-7071 Visit website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Fabrazyme
Fabrazyme (agalsidase beta) is used in the treatment of Fabry disease. Includes Fabrazyme side ...
Galafold
Galafold (migalastat) is used to treat Fabry disease. Includes Galafold side effects, interactions ...
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
More about Elfabrio (pegunigalsidase alfa)
- Check interactions
- Compare alternatives
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: lysosomal enzymes
- Breastfeeding
- En español